PDCD1 and neoplasm: Tumors can downregulate protein p53 or other tumor suppressors, downregulate MHC class I or co-stimulatory molecules on APCs, attract immunosuppressive leucocytes, activate CTLA4, PD1, or other co-inhibitory receptors on T cells [4,59,84,85].